CAR T-Cell Therapy Effective Without Toxicity Risk in Patients With Primary/Secondary CNS Lymphoma
April 25th 2022In this late-breaking poster presented at the Tandem Meetings, investigators recommend that patients with primary or secondary central nervous system lymphoma be included in future clinical trials for CAR T-cell therapy.